Abstract
Two patients are described in whom a clinical and electromyographic diagnosis of the Lambert-Eaton myasthenic syndrome (LEMS) was made. Serum antibodies to voltage-gated calcium channels (VGCCs), the antigenic target in LEMS and to acetylcholine receptors (AChRs), the antigen in myasthenia gravis, were detected at raised titres in both cases, using radioimmunoassays based on 125I-omega-Conotoxin labelled VGCCs and 125I-alpha-Bungarotoxin labelled AChRs. These data provide immunological evidence for the coexistence of the two disorders in these patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Compston D. A., Vincent A., Newsom-Davis J., Batchelor J. R. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain. 1980 Sep;103(3):579–601. doi: 10.1093/brain/103.3.579. [DOI] [PubMed] [Google Scholar]
- Lennon V. A., Lambert E. H. Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc. 1989 Dec;64(12):1498–1504. doi: 10.1016/s0025-6196(12)65705-x. [DOI] [PubMed] [Google Scholar]
- Newsom-Davis J. Autoimmunity in neuromuscular disease. Ann N Y Acad Sci. 1988;540:25–38. doi: 10.1111/j.1749-6632.1988.tb27048.x. [DOI] [PubMed] [Google Scholar]
- O'Neill J. H., Murray N. M., Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain. 1988 Jun;111(Pt 3):577–596. doi: 10.1093/brain/111.3.577. [DOI] [PubMed] [Google Scholar]
- Pfisterer M., Burkart F., Jockers G., Meyer B., Regenass S., Burckhardt D., Schmitt H. E., Müller-Brand J., Skarvan K., Stulz P. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion. Lancet. 1989 Jul 1;2(8653):1–7. doi: 10.1016/s0140-6736(89)90253-5. [DOI] [PubMed] [Google Scholar]
- Sher E., Gotti C., Canal N., Scoppetta C., Piccolo G., Evoli A., Clementi F. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet. 1989 Sep 16;2(8664):640–643. doi: 10.1016/s0140-6736(89)90893-3. [DOI] [PubMed] [Google Scholar]
- Taphoorn M. J., Van Duijn H., Wolters E. C. A neuromuscular transmission disorder: combined myasthenia gravis and Lambert Eaton syndrome in one patient. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):880–882. doi: 10.1136/jnnp.51.6.880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vincent A., Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry. 1985 Dec;48(12):1246–1252. doi: 10.1136/jnnp.48.12.1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Willcox N., Demaine A. G., Newsom-Davis J., Welsh K. I., Robb S. A., Spiro S. G. Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma. Hum Immunol. 1985 Sep;14(1):29–36. doi: 10.1016/0198-8859(85)90062-x. [DOI] [PubMed] [Google Scholar]